Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 203

1.

Test characteristics of the aldosterone-to-renin ratio as a screening test for primary aldosteronism.

Jansen PM, van den Born BJ, Frenkel WJ, de Bruijne EL, Deinum J, Kerstens MN, Smulders YM, Woittiez AJ, Wijbenga JA, Zietse R, Danser AH, van den Meiracker AH.

J Hypertens. 2014 Jan;32(1):115-26. doi: 10.1097/HJH.0b013e3283656b54.

PMID:
24018605
2.

[Aldosterone-to-renin ratio threshold for screening primary aldosteronism in Chinese hypertensive patients].

Chen SX, Du YL, Zhang J, Gong YC, Hu YR, Chu SL, He QB, Song YY, Zhu DL.

Zhonghua Xin Xue Guan Bing Za Zhi. 2006 Oct;34(10):868-72. Chinese.

PMID:
17217708
3.

Analysis of screening and confirmatory tests in the diagnosis of primary aldosteronism: need for a standardized protocol.

Giacchetti G, Ronconi V, Lucarelli G, Boscaro M, Mantero F.

J Hypertens. 2006 Apr;24(4):737-45.

PMID:
16531803
4.

Within-patient reproducibility of the aldosterone: renin ratio in primary aldosteronism.

Rossi GP, Seccia TM, Palumbo G, Belfiore A, Bernini G, Caridi G, Desideri G, Fabris B, Ferri C, Giacchetti G, Letizia C, Maccario M, Mallamaci F, Mannelli M, Patalano A, Rizzoni D, Rossi E, Pessina AC, Mantero F; Primary Aldosteronism in the Prevalence in hYpertension (PAPY) Study Investigators.

Hypertension. 2010 Jan;55(1):83-9. doi: 10.1161/HYPERTENSIONAHA.109.139832. Epub 2009 Nov 23.

5.

Ratio of serum aldosterone to plasma renin concentration in essential hypertension and primary aldosteronism.

Trenkel S, Seifarth C, Schobel H, Hahn EG, Hensen J.

Exp Clin Endocrinol Diabetes. 2002 Apr;110(2):80-5.

PMID:
11928071
6.

Aldosterone-to-renin ratio acts as the predictor distinguishing the primary aldosteronism from chronic kidney disease.

Chen WG, Zhou TT, Zhou P, Li XW, Wu Z, Zhang KY, Xing JC.

Int J Clin Exp Pathol. 2015 Jun 1;8(6):6901-9. eCollection 2015.

7.

Diagnostic accuracy of aldosterone and renin measurement by chemiluminescent immunoassay and radioimmunoassay in primary aldosteronism.

Burrello J, Monticone S, Buffolo F, Lucchiari M, Tetti M, Rabbia F, Mengozzi G, Williams TA, Veglio F, Mulatero P.

J Hypertens. 2016 May;34(5):920-7. doi: 10.1097/HJH.0000000000000880.

PMID:
27031933
8.

Diagnosis of primary aldosteronism: comparison of post-captopril active renin concentration and plasma renin activity.

Wu VC, Kuo CC, Chang HW, Tsai CT, Lin CY, Lin LY, Lin YH, Wang SM, Huang KH, Fang CC, Ho YL, Liu KL, Chang CC, Chueh SC, Lin SL, Yen RF, Wu KD; TAIPAI study group.

Clin Chim Acta. 2010 May 2;411(9-10):657-63. doi: 10.1016/j.cca.2010.01.027. Epub 2010 Feb 1.

PMID:
20117105
9.

[Differences of blood plasma renin activity, angiotensin II and aldosterone levels in essential or secondary hypertension].

Song AL, Zeng ZP, Tong AL, Lu L, Chen S, Li M, Fu CL, Wang YH, Sun ML.

Zhonghua Nei Ke Za Zhi. 2012 Apr;51(4):294-8. Chinese.

PMID:
22781950
10.
11.

[Aldosterone/plasma renin activity ratio is a sensitive parameter for screening patients with primary aldosteronism].

Zhang HL, Liu ZJ, Shao JM, Yan JT, Wang DW.

Zhonghua Xin Xue Guan Bing Za Zhi. 2006 Oct;34(10):873-6. Chinese.

PMID:
17217709
12.

Active renin versus plasma renin activity to define aldosterone-to-renin ratio for primary aldosteronism.

Ferrari P, Shaw SG, Nicod J, Saner E, Nussberger J.

J Hypertens. 2004 Feb;22(2):377-81.

PMID:
15076197
13.

Screening for primary aldosteronism without discontinuing hypertensive medications: plasma aldosterone-renin ratio.

Gallay BJ, Ahmad S, Xu L, Toivola B, Davidson RC.

Am J Kidney Dis. 2001 Apr;37(4):699-705.

PMID:
11273868
14.

[Analysis of characteristics of renin, aldosterone and aldosterone/renin ratio in patients with aldosterone-producing adenoma].

He YB, Yu X, Zhou XR, Shu BH, Liu JH.

Zhonghua Yi Xue Za Zhi. 2013 Nov 12;93(42):3379-83. Chinese.

PMID:
24418036
15.

The cutoff value of aldosterone-to-renin ratio for the diagnosis of primary aldosteronism in patients taking antihypertensive medicine.

Niizuma S, Nakahama H, Kamide K, Fukuchi K, Iwanaga Y, Nakata H, Yoshihara F, Horio T, Nakamura S, Kawano Y.

Clin Exp Hypertens. 2008 Oct;30(7):640-7. doi: 10.1080/10641960802443282.

PMID:
18855267
16.

Captopril suppression: limitations for confirmation of primary aldosteronism.

Westerdahl C, Bergenfelz A, Isaksson A, Valdemarsson S.

J Renin Angiotensin Aldosterone Syst. 2011 Sep;12(3):326-32. doi: 10.1177/1470320310390405. Epub 2011 Jan 27.

PMID:
21273222
17.

One-hour upright posture is an ideal position for serum aldosterone concentration and plasma renin activity measuring on primary aldosteronism screening.

Yin G, Zhang S, Yan L, Wu M, Xu M, Li F, Cheng H.

Exp Clin Endocrinol Diabetes. 2012 Jul;120(7):388-94. doi: 10.1055/s-0032-1301894. Epub 2012 Jun 11.

PMID:
22689101
18.

Indicators of mineralocorticoid excess in the evaluation of primary aldosteronism.

Balaş M, Zosin I, Maser-Gluth C, Hermsen D, Cupisti K, Schott M, Schinner S, Knoefel WT, Scherbaum WA, Willenberg HS.

Hypertens Res. 2010 Aug;33(8):850-6. doi: 10.1038/hr.2010.76. Epub 2010 Jun 3.

PMID:
20520614
19.

Reliability of a Bayesian network to predict an elevated aldosterone-to-renin ratio.

Ducher M, Mounier-Véhier C, Lantelme P, Vaisse B, Baguet JP, Fauvel JP.

Arch Cardiovasc Dis. 2015 May;108(5):293-9. doi: 10.1016/j.acvd.2014.09.011. Epub 2015 Apr 6.

Supplemental Content

Support Center